Medicine & Life Sciences
Coronavirus
100%
Severe Acute Respiratory Syndrome
83%
SARS Virus
50%
Antibody Formation
48%
Fatty Liver
36%
Neutralizing Antibodies
31%
Vaccination
31%
Immunity
30%
B-Lymphocytes
28%
Antibodies
27%
Outpatients
26%
Human Influenza
23%
Immunoglobulin G
22%
Viruses
21%
Plasmalogens
19%
Vaccines
19%
Choline Deficiency
19%
Antibody Diversity
19%
Fatty Acids
18%
Choline
18%
Influenza Vaccines
18%
Methionine
17%
Hospitalization
17%
Post-Exposure Prophylaxis
16%
Body Mass Index
16%
Germinal Center
15%
Receptor for Advanced Glycation End Products
15%
Influenza A virus
13%
Frailty
13%
Liver
13%
Androgen Receptors
12%
Apolipoproteins E
12%
Diet
11%
Adaptive Immunity
11%
Infections
11%
Antiviral Agents
11%
Liver Diseases
11%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
11%
Lipid Metabolism
11%
Nose
11%
Interleukin-1beta
10%
Transgenic Mice
10%
Messenger RNA
10%
Health Personnel
9%
Immunoglobulin M
9%
Non-alcoholic Fatty Liver Disease
9%
Pregnancy
9%
Sterol Regulatory Element Binding Protein 1
9%